IA2030 Scorecard
—Global
Type to select a Country
Target: At least
500
cumulative vaccine introductions in low- and middle-income countries by 2030
Vaccine introductions | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Total | 166 | 59 | 36 | 47 |
Covid | 122 | 0 | 0 | 0 |
DTP Booster 1 | 1 | 2 | 1 | 1 |
DTP Booster 2 | 0 | 4 | 0 | 1 |
DTP Booster 3 | 1 | 4 | 0 | 0 |
HPV | 5 | 11 | 7 | 6 |
Hep A | 0 | 0 | 2 | 0 |
HepB BD | 0 | 2 | 1 | 0 |
IPV2 | 20 | 18 | 14 | 10 |
Influenza | 1 | 1 | 1 | 3 |
MCV2 | 3 | 6 | 2 | 1 |
Malaria | 0 | 0 | 0 | 14 |
MenA | 1 | 2 | 1 | 0 |
Mumps | 0 | 0 | 1 | 0 |
PCV | 5 | 3 | 2 | 4 |
Rotavirus | 4 | 1 | 2 | 2 |
Rubella | 0 | 2 | 0 | 3 |
Typhoid | 2 | 2 | 1 | 1 |
Varicella | 0 | 0 | 1 | 1 |
Yellow Fever | 1 | 1 | 0 | 0 |